About Isatuximab
            
            Class: | Monoclonal antibody (anti-CD38)  
Use: | Treatment of multiple myeloma in combination with other therapies for patients who have received at least one prior therapy  
Adult dose: | 10 mg/kg administered intravenously once weekly for the first 4 weeks, followed by 20 mg/kg once every 2 weeks  
Pediatric dose: | Safety and efficacy have not been established in pediatric patients  
Side effects: | Infusion-related reactions, fatigue, diarrhea, upper respiratory tract infections, nausea, an
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (anti-CD38)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of multiple myeloma in combination with other therapies for patients who have received at least one prior therapy
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Sanofi Aventis Groupe, FRANCE
                    
                    
                    Package Size
                    1 Glass Vial (25ml)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 16102.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        10 mg/kg administered intravenously once weekly for the first 4 weeks, followed by 20 mg/kg once every 2 weeks
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Infusion-related reactions, fatigue, diarrhea, upper respiratory tract infections, nausea, and anemia
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to isatuximab or any component of the formulation
         
        
        
            
                Important Warnings
            
            Risk of serious infusion-related reactions; monitor patients during and after infusion. Risk of infections due to immunosuppression; consider prophylactic measures.
         
        
        
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Monoclonal antibody (anti-CD38) medicines available in UAE pharmacies
            
            
            
                Daratumumab
            
            
            
                Daratumumab
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.